chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On Saturday after vaccine on Friday, Nauseated, muscle aches, fatigue, and Headaches with severe cramping.  Sunday left arm had large raised area at the injection site and felt hot to touch with redness at the site.  Swelling and redness worsened on Monday with itching and a red macule to the left shoulder appeared Monday.  Still ongoing. Patient taking Doxycycline 100 mg twice daily and Kenalog cream.
within couple of hours of receiving vaccine my feet were tingling and felt like pins & needles were being pushed in them.  One week later my feet are still tingling.  Felt extremely tired.   Other random muscle twitches.  Sore arm
History of coronary disease with CABG and heart failure with preserved ejection fraction is evaluated for weakness and shortness of breath. Pt has cold-like symptoms. Pt is found to be COVID positive and is admitted for acute hypoxic respiratory failure and atrial fibrillation with RVR.
Myocarditis.  Chest pain started at 5am, approximately 19 hours after vaccination.   Patient's symptoms mimicked those of a hear attack.  Patient taken to the hospital on Thursday morning after shortness of breath developed.  Pain was radiating down his arm and to his back.  Patient was admitted on Thursday after being at the ER.
Fatigue; moderate cold like symptoms; mild congestion; slight post nasal drip; headache; This is a spontaneous report from a contactable consumer (patient himself). A 31-years-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EL3247) via an unspecified route of administration, administered in left arm on 10Feb2021 at 01:30 as single dose for COVID-19 immunization. The patient's medical history included seasonal allergies and previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247) via an unspecified route of administration, administered in left arm on 20Jan2021 at 12:45 as single dose for COVID-19 immunization. Concomitant medication(s) included acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN), vitamin c [ascorbic acid] (VITAMIN C), vitamin d and [vitamin d nos] (VITAMIN D). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 11Feb2021, the patient experienced fatigue and moderate cold like symptoms (mild congestion, slight post nasal drip, headache). The patient did not received treatment for the events. The outcome of the events was not recovered.
After receiving vaccine - pt developed 1" x 1" wheal at site - (approx. 4 hours post injection) - after 20 hrs. increased to 3" x 3" at office at 24hr mark measured 2 1/4" x 1 3/4" itchy, red, and pain, no fever.
Received vaccine 10/1/15 at 5:45 PM. Around 10 PM developed redness and itching. By Friday developed temp of 102. Body aches and stiff neck. Treated with ADVIL-resolved.
Increased menstruation; Abnormal vaginal bleeding.; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8732) via an unspecified route of administration in the left arm on 26Mar2021 at 16:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and asthma. The patient was allergic to shellfish. The patient received unspecified medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021 at 18:00, the patient experienced increased menstruation during her regular cycle and her cycle was over but she was experiencing abnormal vaginal bleeding. The patient did not receive any treatment for the reported events. The clinical outcome of the events increased menstruation and abnormal vaginal bleeding was not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
Patient reports that she had itching and redness rash type  around the site of the injection spread out about 3 - 4 inches and extreme soreness  7-10 days after receiving injection.  13 days later, redness still present. Intermittently itchy, showing visible improvement on rash from reddish to pinkish. No systemic reaction noted by patient.
covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid) in a 5-decade-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: Janssen COVID-19 Vaccine (Lot 042A21A) on 06-Apr-2021; for an unreported indication: PFIZER BIONTECH COVID-19 VACCINE (Lot 051F21A) on 11-Nov-2021 and PFIZER BIONTECH COVID-19 VACCINE (Lot 0H9702) on 10-Oct-2022. Concurrent medical conditions included Drug allergy.    On 22-Sep-2023, the patient received fourth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. In October 2023, the patient experienced COVID-19 (covid). At the time of the report, COVID-19 (covid) had not resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication and treatment were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-747371 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-747371:Same Reporter (Patient 1)
8/19/08 11:30 AM CLIENT WALKED IN REPORTED BILATERAL AXILLA SWOLLEN DUE TO IMMUNIZATIONS SHE RECEIVED ON 7/30/09.  SWELLING STARTED 2 DAYS AFTER VACCINATION ON 8/1/08 SWELLING REDUCING IN SIZE CLIENT ASSESSED BY NP.
Admitted to hospital for C19 and worsening SOA. tested positive on 7/4
This case was reported by a physician via call center representative and described the occurrence of adverse event in a patient who received BEXSERO. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, unknown after receiving BEXSERO, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown. The reporter considered the adverse event to be possibly related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. The patient had an emergency visit after vaccination. Clarification for the event experienced by the patient had been requested. It was unknown if the suspect vaccine was discontinued. It was unknown if the patient to be admitted to the hospital overnight or prolonged an existing hospitalization. No other seriousness criteria such as death, disabling, congenital anomaly, life-threatening and clinical intervention required was associated with the reported event.
Started with severe headache and tired. I expected that. But the constant headache went away after two days and shifted into an evening headache. Now I have a rather severe headache every single night. I expected that it would go away within a week, but it did not. Every day at about 6pm the headache starts. 600mg Ibuprofen help to dull the pain, but nothing seems to make it go away.
Chills; Fever (99.7 body temperature); This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PYREXIA (Fever (99.7 body temperature)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced CHILLS (Chills) and PYREXIA (Fever (99.7 body temperature)). At the time of the report, CHILLS (Chills) and PYREXIA (Fever (99.7 body temperature)) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-May-2021, Body temperature: 99.7 (Inconclusive) Fever (99.7 body temperature).         Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not applicable.
The patient developed delirium, worsening falls with fever.  She was admitted and underwent LP with elevated protein.  She was discharged and returned on October 25, 2022 and admitted to ICU with worsening agitated delirium, acute renal injury, and lactic acidosis.  ICU service consulted this evening to assist with her complexity and agitated delirium.
Fever 101 5/2/05. 5/8/05 ataxia unable to walk c/o headache. 08/17/05 Information from Discharge summary and medical records submitted with 60 day letter includes infect viral, anorexia, agitation, asthenia and cellebellar syndrome.   He was seen in office last time on 10-18-05.  There was no problems at that time
Pt experienced itching at injection site.  Pt began sniffling and developed generalized hives on arms, neck, and face.  Pt experienced coughing and had tightness of chest. Treated with Benadryl and recovered within 24 hours.
Pt reports left lower quadrant pain, nausea, and metallic taste in mouth one day following the injection. Nausea has resolved, but LLQ pain and metallic taste persists.
I had a very bad case of Covid in January 2021 and have not regained my taste or smell.  I was in bed for 2 weeks and had a prolonged fever up to 105 degrees--so high that I had visual and auditory hallucinations.  I had hair loss in the following months and I also continue to be fatigued.    I received the vaccination on 4/6/21 around 11am; a slight headache and face flushing occurred about 30 minutes after shot, but generally felt ok.  Woke up at 4am on 4/7/21 with chills, extreme joint pain, body aches, migraine headache, and a fever of 101.5 degrees.  Took Tylenol around 6am and went back to bed.  The migraine headache, chills, body aches, and extreme joint pain continued.  I was dizzy and extremely fatigued.  Woke up around 9 am and fever was at 102.7 degrees.  Joint pain and headache were almost unbearable at this point and I took a hydrocodone.  Took temperature around 12 pm and it was 103.5 degrees.  Fever continued rising to 104.4 degrees at 2:30 pm.  Took another Tylenol and went to sleep.  The next day, my fever had fallen back down to 102.5 degrees.  I continued with Tylenol to control me fever to around 101 degrees.   My fever persisted for 3 days.  I still have extreme fatigue, joint pain, burning scalp (which will likely mean more hair loss), zero appetite and weight loss, dizziness, blurred vision, etc.  The side effects are exactly how i felt when I got Covid in January.
Pt. got an immediate red rash around the injection site (approx. 3" in diameter). Pt. felt faint for about 5 min. but this passed. Arm sore & ached for 48 hrs. Rash resolved within 24 hrs. No swelling.
Pounding headache; Underage received vaccine; This spontaneous case was reported by a nurse and describes the occurrence of HEADACHE (Pounding headache) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Underage received vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ETHINYLESTRADIOL, NORGESTIMATE (SPRINTEC) for Birth control.    On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Underage received vaccine). On 26-May-2021, the patient experienced HEADACHE (Pounding headache). The patient was treated with IBUPROFEN for Headache, at an unspecified dose and frequency. On 25-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Underage received vaccine) outcome was unknown. At the time of the report, HEADACHE (Pounding headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Fever 104 degrees, fever after shots at 6 months old, as well as when he got DAPT, HIB,HBV, and PCV7.
Within about 10 minutes after the injection, I experienced the onset of generalized arthralgias, malaise and fatigue that worsened over the next 30 minutes. I had a bright red tender circular area about the size of a quarter within the first 30 minutes. I fell asleep for about 2 1/2 hours. When I awoke, I continued to feel extremely tired and the injection site got hot with worsening redness and tenderness with increased size to about 7 x 5 cms. Over the next 24-48 hours. I never had a fever or any of my worsening of my MG related diplopia, although my eyes were very sensitive to light and I had some neck muscle and generalized weakness, which I experience intermittently with my MG when I am exhausted or acutely ill. I took ADVIL and/or TYLENOL for the malaise and injection site pain.
Patient was given 1st dose in his left arm 6 hours after first vial puncture.; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was given 1st dose in his left arm 6 hours after first vial puncture.) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was given 1st dose in his left arm 6 hours after first vial puncture.). On 15-Mar-2021, EXPIRED PRODUCT ADMINISTERED (Patient was given 1st dose in his left arm 6 hours after first vial puncture.) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatments were reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: NNI
site pain; fatigue; joint and muscle pain; muscle pain; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced pain (Verbatim: site pain), fatigue (Verbatim: fatigue), joint pain (Verbatim: joint and muscle pain) and muscle pain (Verbatim: muscle pain). The outcome of the pain, fatigue, joint pain and muscle pain were not reported.   It was unknown if the reporter considered the pain, fatigue, joint pain and muscle pain to be related to Arexvy.   It was unknown if the company considered the pain, fatigue, joint pain and muscle pain to be related to Arexvy.   Additional Information: GSK receipt date: 23-OCT-2023 This case was reported by a consumer via (Open field AE monitoring) interactive Digital Media.  The patient felt site pain, fatigue, joint and muscle pain. The follow up would not possible as no contact details were available.
pain in lower left side; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain in lower left side) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (pain in lower left side). At the time of the report, PAIN (pain in lower left side) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
I have had  Post Acute Covid-19 syndrome  since Nov 4, 2020. The first night after receiving my first vaccine I got the chills about 16 hours after my shot went away after a few hours. Woke of the next day with my post acute syndrome symptoms  much worse than I had prior to shot,  my fatigue in my legs were to the point I could hardly walk, my brain fog and tremors  were much worse, that lasted about 1 day then the next two nights I woke up in the middle of night with severe sweating. I was then felling like I had before the shot. Then about 4 days after receiving the vaccine the post acute syndrome symptoms again were much worse than before. This last for about 2 weeks then gradual worked back the my original feeling of fatigue, brain fog and tremors  that I had prior to vaccine
Pain, swelling, bruising. Was seen at urgent care and received prednisone and Benadryl.
The next day I have fever, body aches and fatigue. All went away but the fatigue.
Numbness around mouth, cheeks and nose; Feels like I am swallowing around a pistachio; This is a spontaneous report from a non-contactable consumer (patient) or other non hcp. A 54-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown, at the age of 54-year-old), via an unspecified route of administration, administered in arm left on 25Feb2021 18:15 as dose number unknown, single for covid-19 immunization. Patient had no other vaccine in four weeks. Patient had not covid prior vaccination and not tested post vaccination. Patient had no known allergies. The patient medical history was none. Concomitant medications included collagen, colecalciferol (VITAMIN D), ubidecarenone (COQ10) and daily vitamin taken for an unspecified indication. The patient experienced numbness around mouth, cheeks and nose and felt like she was swallowing around a pistachio on 25Feb2021. No treatment received for adverse events. The clinical outcome of events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Patient presented with a "deep cough" and need for increasing O2. Patient resulted positive for COVID.
fast heart beat, 9 days the runs, 1 day total sneezing/headache, 1 day total coughing, 2 weeks nausea, intermittent bruising worse starting May 19, sore left kidney, sore liver area, restless legs syndrome, reverse sleep pattern- awake all night long for 4 or 5 days, extreme weakness, dizziness, eyesight worse, ringing in ears...starting to get better by May 24.
vaccinated with an open vial from 13-Jul-2022 that was not discarded; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccinated with an open vial from 13-Jul-2022 that was not discarded) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B22A) for COVID-19 prophylaxis.     Concurrent medical conditions included Drug allergy (Bactrim), Drug allergy (Hydrochlorothiazide) and Sulfonamide allergy (Sulfa Drugs).    On 14-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccinated with an open vial from 13-Jul-2022 that was not discarded). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccinated with an open vial from 13-Jul-2022 that was not discarded) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The patient date of birth was mentioned.  The patient received the Moderna COVID-19 vaccine booster dose (unknown which booster dose it was) and no side effects had been reported. The reporter had no information on patient's past vaccination history. The events did not cause the patient to seek medical care (office visit, Urgent care, ER, hospitalized).  The vial did not undergo any temperature excursions.  No treatment information was provided by the reporter.
Pt. upon receiving vaccines left the vaccine room with mother and was leaving the waiting area fell in the door way.  Mom reported that the child has a "seizure".  When PHN arrived the child was held by Mom and Phn had mom Lay Her in a reclining position with her feet up.  Child's eyes were half open  and another nurse was with pt. while  Phn Obtained aa blood pressure cuff and ammonia.  Pt. was crying when I returned.  BP was 120/80 RIGHT ARM.  Child remained in Clinic for approx. 30 min.  She was alert and drank some soda. Seen in ER due to an episode of unresponsiveness, while walking out of the health department after her Hib vaccine, she fell down face forward, her mother is not sure if she tripped or not, she was unconscious and arched her back, became stiff all over and had bilateral arms and legs extended, she also stopped breathing for "a few seconds" and turned blue but then regained consciousness. She lost urinary continence during the episode. While driving to ER she became weak.   Appeared to improve and was DC's from ER, while walking to car complained of nausea and became "weak in the knees" almost fell down twice, appeared drowsy. Returned to ER where she looked pale and diaphoretic. Patient stated she does not remember any of that episode. Small amount of yellow emesis.  No HX of fevers, rash, runny nose, vomiting prior to this episode.  Review of Systems: negative. Impression: new onset generalized seizure of unknown cause. No febrile seizure or concussion. Clinical picture does not suggest changed mental status, hypoxia, hypoglycemia, hyponatremia or hypernatremia. Clinical picture does not suggest volume depletion or urinary tract infection.
Patient developed atypical facial paralysis in June 2022 and was treated initially with doxycycline by her lyme specialist. She developed side effects so then treated with cefuroxime. 10 days later she noted significant easy bruising and was found to have platelets of 8,000 8/5/22. Initially treated with dexamethasone 40 mg x4 days, IVIG and platelet transfusion.  Platelets later dropped again and had a second course of dexamethasone.  A third drop of platelets recently and patient is now s/p another course of IVIG, platelet transfusion and now on prednisone taper. Workup for viral illness, nutritional issues have been negative as had initial workup for rheumatologic etiologies but will be repeated as testing done while on steroids
She had mild side effects to the first vaccine; This is a spontaneous case received from a contactable consumer (patient) via a Pfizer sponsored program. A female patient of age 90 (units unspecified) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration, administered on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was not reported) via an unspecified route of administration, administered on an unspecified date for Covid-19 immunization. On an unspecified date, the patient reported that she had mild side effects to the first vaccine. The outcome of the event was unknown.  No follow-up attempts are needed, information about lot/batch number cannot be obtained.
Pt developed varicella b/c he was on ENBREL but his PCP was aware & authorized vaccine.